See What HealthDay Can Do For You
Contact Us

Vitamin D May Help Avert Early Onset of Insulin Resistance

Levels of insulin, HOMA-IR remain steady in those receiving supplements

pills

THURSDAY, March 17, 2016 (HealthDay News) -- Early intervention with vitamin D in deficient individuals may help ward off early onset of insulin resistance, according to a study published online Feb. 18 in Diabetes, Obesity and Metabolism.

Sigal Tepper, Ph.D., from Ben-Gurion University in Beer-Sheva, Israel, and colleagues randomly assigned 130 men without diabetes (average age, 47.52 years) who had 25(OH)D serum levels <20 ng/mL to treatment (100,000 IU vitamin D bimonthly) or placebo.

The researchers found, after adjusting for baseline levels, age, body mass index, sun exposure, physical activity, and low-density lipoprotein cholesterol, that there were significant differences in insulin and homoeostasis model assessment of insulin resistance (HOMA-IR ) between groups. In the treatment group, levels of insulin and HOMA-IR remained steady, but they increased by 16 percent in the control group (P = 0.038 and 0.048, respectively).

"Further studies are needed to establish the long-term effect of vitamin D supplementation on the risk of diabetes," the authors write.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.